This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Seeburger, J. Articles by Aebert, H. Search for Related Content PubMed PubMed Citation Articles by Seeburger, J. Articles by Aebert, H. Pubmed/NCBI databases Substance via MeSH Hazardous Substances DB HEPARIN Related Collections CV surgery: other

(Circulation. 2005;112:I-224 – I-228.)
© 2005 American Heart Association, Inc.

Myocardial Protection and Vascular Biology

Gene Expression Changes in Leukocytes During Cardiopulmonary Bypass Are Dependent on Circuit Coating

Joerg Seeburger, BSc; Jan Hoffmann, MSc; Hans Peter Wendel, PhD; Gerhard Ziemer, MD; Hermann Aebert, MD

From the Department of Thoracic, Cardiac, and Vascular Surgery, Eberhard Karls University, Tuebingen, Germany.

Correspondence to Dr Hermann Aebert, Department of Thoracic, Cardiac, and Vascular Surgery, Eberhard Karls University, Hoppe-Seyler-Str 3, 72076 Tuebingen, Germany. E-mail hermann.aebert{at}med.uni-tuebingen.de

Background— Cardiopulmonary bypass (CPB) results in a systemic inflammatory response. Leukocytes play a crucial role in inflammatory reactions. Their gene expression profile in the context of CPB is unknown.

Methods and Results— In a prospective, randomized, and double-blind clinical trial, 12 male patients underwent elective coronary artery bypass grafting with either heparin-coated (group H) or protein-coated (group P) CPB circuits. Oligonucleotide microarray analyses of 22 283 genes were performed on circulating leukocytes, collected immediately before surgery and 6 hours after CPB. Microarray results were validated with real-time polymerase chain reaction. All patients had uneventful surgery, and no significant differences between groups were observed during the clinical course. Multiple statistical analyses with different methods were performed. Compared with preoperative expression at a threshold value of P<0.01, postoperative expression revealed 814 upregulated and 1187 downregulated genes in group H compared with 99 upregulated and 231 downregulated in group P (P<0.001). Fifty genes exhibited a >4-fold increase and 27 exhibited a >4-fold decrease in group H, whereas only 7 genes exhibited upregulation and 7 revealed downregulation in group P. Microarray-pathway-profile-finder analyses determined 1405 upregulated and 1454 downregulated pathways in group H compared with 552 upregulated and 818 downregulated pathways in group P (P<0.01). Pathways related to inflammatory response exhibited highest z scores in group H, reflecting cellular inflammatory activation.

Conclusions— Heparin coating resulted in a more profound alteration in leukocyte gene expression when compared with protein coating. Microarray analyses present an innovative approach for the evaluation and understanding of inflammatory reactions associated with CPB.

Key Words: cardiopulmonary bypass • genes • inflammation • leukocytes